Cytotoxic T-lymphocyte antigen-4 blockade in melanoma.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 25746738)

Published in Clin Ther on March 06, 2015

Authors

Elizabeth I Buchbinder1, David F McDermott2

Author Affiliations

1: Division of Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. Electronic address: elizabeth_buchbinder@DFCI.harvard.edu.
2: Division of Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.